Novel concepts of neuropeptide-based drug therapy: vasoactive intestinal polypeptide and its receptors.
about
Development of a novel antimicrobial peptide, AG-30, with angiogenic properties.Single-cell profiling reveals heterogeneity and functional patterning of GPCR expression in the vascular system.Cystic fibrosis transmembrane conductance regulator dysfunction in VIP knockout mice.Avoiding mouse traps in schizophrenia genetics: lessons and promises from current and emerging mouse models.Pituitary adenylate cyclase activating polypeptide: an important vascular regulator in human skin in vivo.Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a review.Vasodilatory effect of the stable vasoactive intestinal peptide analog RO 25-1553 in murine and rat lungsAnalysis of airway secretions in a model of sulfur dioxide induced chronic obstructive pulmonary disease (COPD).The VPAC1 receptor: structure and function of a class B GPCR prototype.Nanotechnology-based drug delivery systemsFreeze drying of peptide drugs self-associated with long-circulating, biocompatible and biodegradable sterically stabilized phospholipid nanomicelles.Fluid secretion by submucosal glands of the tracheobronchial airways.Pituitary adenylate cyclase-activating peptide receptor 1 mediates anti-inflammatory effects in allergic airway inflammation in mice.Expression of VPAC1 in a murine model of allergic asthmaFibrosis and loss of smooth muscle in the corpora cavernosa precede corporal veno-occlusive dysfunction (CVOD) induced by experimental cavernosal nerve damage in the rat.Pituitary adenylate cyclase-activating polypeptide (PACAP) contributes to the proliferation of hematopoietic progenitor cells in murine bone marrow via PACAP-specific receptor.VIP-dependent increase in F508del-CFTR membrane localization is mediated by PKCε.Dual bronchodilatory and pulmonary anti-inflammatory activity of RO5024118, a novel agonist at vasoactive intestinal peptide VPAC2 receptors.Spatio-temporal localization of vasoactive intestinal peptide and neutral endopeptidase in allergic murine lungs.Differential cellular expression of organic anion transporting peptides OATP1A2 and OATP2B1 in the human retina and brain: implications for carrier-mediated transport of neuropeptides and neurosteriods in the CNS.The PPI network analysis of mRNA expression profile of uterus from primary dysmenorrheal rats.Vasoactive intestinal peptide suppresses macrophage-mediated inflammation by downregulating interleukin-17A expression via PKA- and PKC-dependent pathways.Therapeutic efficacy of vasoactive intestinal peptide in escherichia coli lipopolysaccharide-induced experimental periodontitis in rats.The calculation of drag on nano-cylindersThe Neural Signals of the Superior Ovarian Nerve Modulate in an Asymmetric Way the Ovarian Steroidogenic Response to the Vasoactive Intestinal PeptideNeuropeptides in asthma, chronic obstructive pulmonary disease and cystic fibrosis
P2860
Q33328109-836F699F-8D4F-4F76-9141-241587D2E1EFQ33826984-63B74200-7463-4A4B-8C72-032B9B1F9C14Q33913037-0EE9CD9A-6B91-46A0-93C3-9AF4C48421CBQ34206314-AA790633-BE20-49CB-AB40-5F9C155C1E36Q34254582-25D6E4E3-9B20-4AC8-A1AD-3CBA614716E9Q34961901-7915B02B-7E88-443D-B4BB-422D965B6B12Q34999736-DE3C819D-3A65-40AE-91A1-EC1C6118059AQ35016089-B6C3FF42-3823-4A18-8466-D45410390C0EQ36403782-D1DEACBE-96F1-4B0B-93F5-232688FF9ABDQ36419770-4CE50D59-928D-4D39-AE16-76EB02DD4FD3Q36700122-1AF2F64D-1DAF-4143-B9DB-ED9ABF337FFAQ36914022-557649C0-D92E-4F0E-8EB1-5DC123F7533DQ36959866-9C6757F9-4C08-496A-978A-D52D35F773F3Q37367392-91D69978-F36E-4AB8-B33F-B614A3603446Q37373199-05489685-48C8-4383-9E50-84FEC0EA782CQ38694548-F2C075AF-2482-464B-9838-4E5AC9B0548BQ39575153-DA3C3A3D-B4AB-4D5F-9FF2-0C5D6EFD5BA3Q41121832-AC824C9C-FA30-44C1-8484-46EB3456E432Q42515995-4D00BDA9-2E3B-4528-842F-FE40F2E42D46Q48598794-961FBCA0-C324-4C47-BD28-14956EECAF42Q49292264-250C6340-36D9-4F68-846A-24F624405712Q53516273-6BE3DAE7-32B1-4C5F-B75B-2E3B3A8BA0FCQ54397909-1F2FC20E-C665-4467-AF26-4D03968D2367Q56483147-35FFDC1B-EAFB-41C5-AF55-2155CD2C9CFCQ58735085-36398628-587E-407F-A12A-A545FD00BD1EQ58798935-80EEF3CC-2CCC-48B5-A9C7-C1D00A1FAC6C
P2860
Novel concepts of neuropeptide-based drug therapy: vasoactive intestinal polypeptide and its receptors.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Novel concepts of neuropeptide ...... polypeptide and its receptors.
@ast
Novel concepts of neuropeptide ...... polypeptide and its receptors.
@en
type
label
Novel concepts of neuropeptide ...... polypeptide and its receptors.
@ast
Novel concepts of neuropeptide ...... polypeptide and its receptors.
@en
prefLabel
Novel concepts of neuropeptide ...... polypeptide and its receptors.
@ast
Novel concepts of neuropeptide ...... polypeptide and its receptors.
@en
P2093
P1476
Novel concepts of neuropeptide ...... polypeptide and its receptors.
@en
P2093
Axel Fischer
David A Groneberg
Klaus F Rabe
P304
P356
10.1016/J.EJPHAR.2005.12.055
P407
P577
2006-02-10T00:00:00Z